Cost Effectiveness of Once-Daily Oral Chelation Therapy with Deferasirox versus Infusional Deferoxamine in Transfusion-Dependent Thalassaemia Patients: US Healthcare System Perspective.
Delea, Thomas E 1; Sofrygin, Oleg 1; Thomas, Simu K 2; Baladi, Jean-Francois 2; Phatak, Pradyumna D 3; Coates, Thomas D 4
[Article] Pharmacoeconomics. 25(4):329-342, 2007.

(Format: HTML, PDF)